GG Ventures (Goddess Gaia Ventures)
All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.
- Tracked funds
- 1
- Reported volume
- €26m
- Latest public closing
- 14 Sept 2025
Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.
London-based venture capital firm investing in technology for women's health.
Focus: Early-stage companies using technology to improve women's health and performance, including fertility, cancer, wellness, chronic conditions and femtech
14 September 2025: GG Ventures announced a $30m first close of Fund II, against a $100m target (company news).
Tracked funds
FundStageHQAs ofAmount €M
Growth seed and Series A in AI-native women's health, sport, longevity and wellness.
- AI, Health & Bio
- Global (women's health, sport, longevity)
- USD
- Fund 2
- 14 Sept 2025
- GG Ventures (Goddess Gaia Ventures)
- USD 30m First Close; target USD 100m